MARKET

HUMAW

Humacyte Inc
HUMAW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0035
0.0849
0.0080
-
Weekly Report: what happened at HUMA last week (1019-1023)?
Weekly Report · 22h ago
Humacyte's ATEV Shows Phase 3 Benefits In Women, Supports Planned FDA Label Expansion
NASDAQ · 3d ago
Humacyte Presents Interim Results From V012 Phase 3 Clinical Trial Of Acellular Tissue Engineered Vessel In Arteriovenous Access For Female Hemodialysis Patients, At ASN Kidney Week 2026
Benzinga · 3d ago
Weekly Report: what happened at HUMA last week (1012-1016)?
Weekly Report · 10/19 10:07
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 10/16 21:05
Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Healthequity (HQY)
TipRanks · 10/16 10:40
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 10/15 17:05
Humacyte Reports Accelerating Commercial Adoption, Reports 44% Increase In Hospitals Ordering Symvess To 49 In Q3 2026
Benzinga · 10/15 13:18
More

Webull offers Humacyte Inc stock information, including NASDAQ: HUMAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HUMAW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HUMAW stock methods without spending real money on the virtual paper trading platform.